Mutational Analysis of the Cy Motif from p21 Reveals Sequence Degeneracy and Specificity for Different Cyclin-Dependent Kinases
Open Access
- 1 August 2001
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 21 (15), 4868-4874
- https://doi.org/10.1128/mcb.21.15.4868-4874.2001
Abstract
Inhibitors, activators, and substrates of cyclin-dependent kinases (cdks) utilize a cyclin-binding sequence, known as a Cy or RXL motif, to bind directly to the cyclin subunit. Alanine scanning mutagenesis of the Cy motif of the cdk inhibitor p21 revealed that the conserved arginine or leucine (constituting the conserved RXL sequence) was important for p21's ability to inhibit cyclin E-cdk2 activity. Further analysis of mutant Cy motifs showed, however, that RXL was neither necessary nor sufficient for a functional cyclin-binding motif. Replacement of either of these two residues with small hydrophobic residues such as valine preserved p21's inhibitory activity on cyclin E-cdk2, while mutations in either polar or charged residues dramatically impaired p21's inhibitory activity. Expressing p21N with non-RXL Cy sequences inhibited growth of mammalian cells, providing in vivo confirmation that RXL was not necessary for a functional Cy motif. We also show that the variant Cy motifs identified in this study can effectively target substrates to cyclin-cdk complexes for phosphorylation, providing additional evidence that these non-RXL motifs are functional. Finally, binding studies using p21 Cy mutants demonstrated that the Cy motif was essential for the association of p21 with cyclin E-cdk2 but not with cyclin A-cdk2. Taking advantage of this differential specificity toward cyclin E versus cyclin A, we demonstrate that cell growth inhibition was absolutely dependent on the ability of a p21 derivative to inhibit cyclin E-cdk2.Keywords
This publication has 26 references indexed in Scilit:
- A Bipartite Substrate Recognition Motif for Cyclin-dependent KinasesJournal of Biological Chemistry, 2001
- SSeCKS, a Major Protein Kinase C Substrate with Tumor Suppressor Activity, Regulates G1→S Progression by Controlling the Expression and Cellular Compartmentalization of Cyclin DMolecular and Cellular Biology, 2000
- β3-Endonexin as a Novel Inhibitor of Cyclin A-Associated KinaseBiochemical and Biophysical Research Communications, 2000
- Evolving Ideas about CyclinsCell, 1999
- Tenascin-C Hexabrachion Assembly Is a Sequential Two-step Process Initiated by Coiled-coil α-HelicesJournal of Biological Chemistry, 1998
- CYCLIN-DEPENDENT KINASES: Engines, Clocks, and MicroprocessorsAnnual Review of Cell and Developmental Biology, 1997
- Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complexNature, 1996
- Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complexNature, 1995
- Principles of CDK regulationNature, 1995
- Separate domains of p21 involved in the inhibition of Cdk kinase and PCNANature, 1995